TALEN

TALEN4-flt4

ID

ZDB-TALEN-150403-6

Name

TALEN4-flt4

Previous Names

None

Target

flt4 (1)

Target Sequence 1

5' - CTTCATAACAGACTCT - 3'

Target Sequence 2

5' - CTGAAACCAGACATGGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
um131	flt4

Expression

Gene expression in Wild Types + TALEN4-flt4

No data available

Phenotype

Phenotype resulting from TALEN4-flt4

No data available

Phenotype of all Fish created by or utilizing TALEN4-flt4

Phenotype	Fish	Conditions	Figures
posterior cardinal vein flt4 expression decreased amount, abnormal	flt4^um131/um131	standard conditions	Fig. 1 from Shin et al., 2016
intersegmental vein decreased amount, abnormal	flt4^um131/um131	standard conditions	Fig. 3 from Shin et al., 2016
endothelial cell flt4 expression decreased amount, abnormal	flt4^um131/um131	standard conditions	Fig. 1 from Shin et al., 2016
posterior cardinal vein vascular sprouts Ab2-tek labeling absent, abnormal	flt4^um131/um131	standard conditions	Fig. 3 from Shin et al., 2016
intersegmental artery increased amount, abnormal	flt4^um131/um131	standard conditions	Fig. 3 from Shin et al., 2016
eye anatomical region edematous, abnormal	flt4^um131/um131	standard conditions	Fig. 6 from Shin et al., 2016
posterior caudal vein vascular sprouts decreased amount, abnormal	flt4^um131/um131	standard conditions	Fig. 3 from Shin et al., 2016
heart anatomical region edematous, abnormal	flt4^um131/um131	standard conditions	Fig. 6 from Shin et al., 2016
swim bladder inflation decreased occurrence, abnormal	flt4^um131/um131	standard conditions	Fig. 6 from Shin et al., 2016
digestive system anatomical region edematous, abnormal	flt4^um131/um131	standard conditions	Fig. 6 from Shin et al., 2016
thoracic duct lymph vessel development process quality, abnormal	flt4^um131/+; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
thoracic duct lymph vessel development decreased occurrence, abnormal	flt4^um131/+; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
thoracic duct malformed, abnormal	flt4^um131/+; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
lateral facial lymph vessel lymphangiogenic sprout DsRed expression absent, abnormal	flt4^um131/um131; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
otolithic lymph vessel absent, abnormal	flt4^um131/um131; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
lateral facial lymph vessel lymphangiogenic sprout absent, abnormal	flt4^um131/um131; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
otolithic lymph vessel DsRed expression absent, abnormal	flt4^um131/um131; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
lateral facial lymph vessel truncated, abnormal	flt4^um131/um131; nz101Tg	standard conditions	Fig. 7 from Shin et al., 2016
lymphangiogenic sprout decreased amount, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
lateral facial lymph vessel lymph vessel development process quality, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 7 from Shin et al., 2016
primordial hindbrain channel malformed, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
primordial hindbrain channel absent, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
thoracic duct lymph vessel development decreased occurrence, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
lateral facial lymph vessel closed, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 7 from Shin et al., 2016
parachordal vessel absent, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
intersegmental vein EGFP expression absent, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
thoracic duct absent, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
primordial hindbrain channel vasculature development decreased occurrence, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 2 from Shin et al., 2016
lateral facial lymph vessel malformed, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 7 from Shin et al., 2016
parachordal vessel vasculature development decreased occurrence, abnormal	flt4^um131/um131; y1Tg	standard conditions	Fig. 3 from Shin et al., 2016
endothelial cell ab9-mapk labeling decreased amount, abnormal	kdrl^y17; flt4^um131/um131	standard conditions	Fig. 2 from Shin et al., 2016

Citations